PubMed · 3890708
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
S Sherry, E Gustafson. 1985. The current and future use of thrombolytic therapy.. https://doi.org/10.1146/annurev.pa.25.040185.002213
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Immune heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin. It can result from any type of heparin exposure and by any route of administration; however only a few cases are reported after exposures to small quantities of heparin from catheter flushes. The major clinical problem associated with HIT is thrombosis. Early detection and institution of alternative, non-heparin anticoagulation are important. We report a patient with HIT associated with use of therapeutic-dose unfractionated heparin in whom immune sensitization to heparin was triggered by two 500-unit exposure to UFH associated with intravascular catheter flushing for antineoplastic chemotherapy in a patient with colon adenocarcinoma.
Explore the source record for details and available documents.
Explore the source record for details and available documents.